Posts

Keeping up with Belgian Patent Litigation – mid-2025 - mid-2026

Fordham 32 (Report 1): Patents in Pharma

Can Unified Patent Court and national laws of infringement diverge? An IPKat dialogue

More on amendments to Bolar provisions - this time in Ireland

An elegant way to have different defences to patent infringement under the UPC? UK IPO may have found one...

Astellas Pharma: your chance to comment

Patent infringement, the Bolar exemption and suppliers: questions for the CJEU